KYBORA Welcomes Vladyslava Bab’yak as an Analyst

KYBORA, a global healthcare advisory firm and investment bank, is proud to announce that Vladyslava Bab'yak has joined the company as an Analyst. With a double Master’s degree in Finance with…
READ MORE

KYBORA’s Most Requested Consulting Services

Developing groundbreaking therapies, commercializing products, and/or finding the right partners are all essential activities for successful biotech companies. These tasks…
READ MORE

The Impact of the Inflation Reduction Act (IRA) on Orphan Drugs

Sept. 27, 2023 - The Impact of the Inflation Reduction Act (IRA) on Orphan Drugs - ORPHAN Cures Act introduced…
READ MORE

Competition in the Biotech Industry

The biotech industry is characterized by intense competition stemming from scientific breakthroughs, innovative therapies, and cutting-edge technologies. Biotech CEOs encounter…
READ MORE

Navigating the Complexities of Market Access and Reimbursement in the US Biotech Industry

In the intricate landscape of biotechnology, the path to introducing innovative products comes with challenges that require strategic expertise. Overcoming…
READ MORE

Navigating Biotech Product Licensing in China: Bridging Opportunity and Complexity

Embarking on the global biotech stage, the allure of the Chinese market beckons with undeniable potential. Yet, the path to…
READ MORE

Navigating the Complex Intellectual Property Landscape as a Biotech CEO

As a Biotech CEO, steering a company through the dynamic landscape of innovation comes with a unique set of challenges,…
READ MORE

Exploring Funding Avenues for your Biotech Venture

In the dynamic landscape of biotech, securing the right funding is the heartbeat of progress. For innovative startups in this…
READ MORE

Licensing Strategies for Biotech CEOs

Biotech research and development serve as the bedrock of groundbreaking advancements, but the journey often demands substantial financial backing. CEOs…
READ MORE

KYBORA is pleased to announce that Wang Zhi has joined its team at EVP and Managing Director of its Asia Pac operations.

SHANGHAI AND PRINCETON, N.J. JUNE 09, 2023KYBORA Life Sciences, a global advisory firm dedicated to facilitating enduring success for life…
READ MORE

Q1 2023 Global Biopharma Market Trends and News

In this report (download here) , Q1 2023 Global Biopharma Market Trends and News, we cover the key Biotech/Pharma trends…
READ MORE

KYBORA is happy to announce that Khai Meng Ang has joined its team as Senior Advisor for China.

KYBORA's mission is to help life science companies achieve enduring success. Khai's addition to our team allows us to provide…
READ MORE

KYBORA announces that Megalabs has acquired acquired Fr!ska

KYBORA is pleased to announce that its client Megalabs has acquired acquired Fr!ska.
READ MORE

TYPE & ENTER: